logo
Tony's Chocolonely bars recalled for possibly containing ‘small stones'

Tony's Chocolonely bars recalled for possibly containing ‘small stones'

Yahoo02-04-2025
A chocolate manufacturer has issued a voluntary recall of certain chocolate bars sold in the U.S. and Canada, because they could contain "small stones."
Tony's Chocolonely Inc., based in Amsterdam, Netherlands and has offices in places like New York City, announced the recall on Monday, saying the chocolate bars in question were distributed to retailers in Canada and the U.S.
According to the announcement, seven lots of Tony's brand Dark Almond Sea Salt Bar (6.35 oz) and Everything Bar (6.35 oz) were being recalled "because the product may contain small stones."
The candy bars were sold in U.S. retail stores and on the company's website, www.tonyschocolonely. The notice said distribution of the recalled bars began on Feb. 7 and ended on March 24.
Fda Recalls Cheese Sold At Aldi Locations In 4 States
"Whilst the chance of any individual product being affected is low, we have decided to take this step to ensure the safety and satisfaction of Tony's Chocolonely consumers," the company said.
Read On The Fox Business App
The company added that a limited number of consumers reported that they found small stones in the product, which were not filtered during third-party almond harvesting and almond processing.
The products being recalled are identified with the following lot code, best-by date and UPC:
Tony's Chocolonely Everything Bar (180g / 6.35 oz):
4327, 22-Nov-25, 850011828564
4330, 25-Nov-25, 850011828564
4331, 26-Nov-25, 850011828564
M4331, 26-Nov-25, 850032676441
Thousands Of Pounds Of Ground Coffee Recalled Due To Mislabeling Error: Fda
Tony's Chocolonely Dark Chocolate Almond Sea Salt (180g / 6.35 oz):
163094, 2-Apr-26, 858010005641
162634, 28-Feb-26, 858010005641
M162634, 28-Feb-26, 850011828908
In Canada, Dark Almond Sea Salt, 180g products, with a lot number of 162697, and Everything bar, 180g products, with a lot number of 4332, were also recalled.
Trader Joe's Recalls Sparkling Water Bottles Over 'Laceration Hazard': 'Dispose Of Them Carefully'
Lot codes are unique identifiers assigned to a batch or quantity of products manufactured under the same conditions and used for tracking and traceability, the company said.
For the bars in question, the lot code is printed on the side of the candy bar wrapper and usually starts with the letter "L" for everyday items, and "M" for personalized items.
No other lot codes were included in the voluntary recall, and Tony's Chocolonely said the action was taken to ensure the safety of its consumers, as a precautionary measure.
Click Here To Read More On Fox Business
Consumers who possess one of the candy bars in question are encouraged to return the item to the store it was purchased from for a refund or replacement or simply dispose of the product.Original article source: Tony's Chocolonely bars recalled for possibly containing 'small stones'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Crinetics' treatment of CAH granted FDA orphan designation
Crinetics' treatment of CAH granted FDA orphan designation

Business Insider

timean hour ago

  • Business Insider

Crinetics' treatment of CAH granted FDA orphan designation

Crinetics (CRNX)' treatment of congenital adrenal hyperplasia, generic name atumelnant, was granted FDA orphan designation, according to a post to the agency's site. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Keros Therapeutics' treatment of Duchenne MD granted FDA orphan designation
Keros Therapeutics' treatment of Duchenne MD granted FDA orphan designation

Business Insider

timean hour ago

  • Business Insider

Keros Therapeutics' treatment of Duchenne MD granted FDA orphan designation

Keros Therapeutics (KROS)' treatment of Duchenne muscular dystrophy was granted FDA orphan designation, according to a post to the agency's site. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Regenxbio announces FDA review extension for RGX-121 BLA
Regenxbio announces FDA review extension for RGX-121 BLA

Business Insider

time3 hours ago

  • Business Insider

Regenxbio announces FDA review extension for RGX-121 BLA

Regenxbio (RGNX) announced that the U.S. Food and Drug Administration extended its review timeline of the Biologics License Application for clemidsogene lanparvovec for the treatment of Mucopolysaccharidosis II, also known as Hunter syndrome. The Prescription Drug User Fee Act goal date has been extended from November 9, 2025 to February 8, 2026. The extension follows the company's submission of longer-term clinical data for all patients in the pivotal study of RGX-121 in response to an FDA information request. These positive 12-month clinical data are consistent with biomarker and neurodevelopmental data previously submitted on the same patients in the BLA and will be presented during the International Congress of Inborn Errors of Metabolism in September 2025. In August 2025, the FDA completed a pre-license inspection and bioresearch monitoring information inspection for the RGX-121 BLA with no observations. No safety-related concerns have been raised by the FDA during the BLA review. 'Boys with this rare, devastating disease have no treatment options to address neurodevelopmental decline, and the Hunter syndrome community is in urgent need for a therapeutic option with the potential to improve these patients' lives,' said Curran M. Simpson, President and Chief Executive Officer of REGENXBIO. 'We promptly provided the FDA with the information requested and expect the commercial launch plans remain on track.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store